Table 2.
The baseline data for patients with IgAN and healthy controls.
| Characters | Mean ± SD or n (%) | ||
|---|---|---|---|
| IgAN | Healthy controls | P | |
| Male/female | 11/10 | 9/9 | |
| Age (mean ± SD, year) | 39 ± 12 | 37 ± 13 | 0.84 |
| SBP (mmHg) | 125 ± 18 | 126 ± 16 | 0.67 |
| Proteinuria (g/d, median, IQR) | 1.18 (0.48-3.39) | ||
| Plasma IgA1 (μg/mL, median, IQR) | 1810 (1445-2153) | 1450 (840-1758) | 0.04 |
| eGFR (mL/min/1.73/m2) | 82.81 ± 25.78 | ||
| Oxford classification (%) | |||
| M score (M0/M1) | 4 (19)/17 (81) | ||
| E score (E0/E1) | 12 (57.1)/9 (42.9) | ||
| S score (S0/S1) | 11 (52.4)/10 (47.6) | ||
| T score (T0/T1/T2) | 9 (42.8)/9 (42.8)/3 (14.4) | ||
| C score (C0/C1/C2) | 5 (23.8)/9 (42.8)/7 (33.4) | ||
SD: standard deviation; SBP: systolic blood pressure; eGFR: estimated glomerular filtration rate.